期刊文献+

18^F-氟脱氧葡萄糖PET在淋巴瘤中的应用价值

The value of 18^F-fluorodeoxyglucose PET in lymphomas
原文传递
导出
摘要 淋巴瘤的发病率逐年升高,18^F-氟脱氧葡萄糖(18^F—FDG)PET作为一种全身性功能代谢显像手段在淋巴瘤的诊断、分期、治疗方案的选择、疗效的评价及残留肿块性质的判断方面具有重要价值,较常规影像学检查提供更多有价值的信息而得到临床的广泛认可,但仍有一定的假阳性及假阴性。 The morbidity of lymphomas increased yearly. As a whole-body functional metabolic imaging modality, 18^F-FDG PET was very valuable in the diagnosing, staging, selecting treatment program, evaluating therapeutic response and differentiating residual mass. PET had been recognized as a helpful modality because it can provide much more additional information than conventional imaging. However, there was some false positive and false negative.
作者 张悦 高硕
出处 《国际放射医学核医学杂志》 2007年第5期292-295,共4页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 淋巴瘤 体层摄影术 发射型计算机 氟脱氧葡萄糖F18 Lymphomas Tomography, emission-computed FluorodeoxyglucoseF18
  • 相关文献

参考文献19

  • 1Schaefer NG, Hany TF, Taverna C, et al. Non-Hodgkin lymphoma and Hodgkin Disease: coregistered FDG PET and CT at staging and restaging-do we need contrast-enhanced CT?. Radiology, 2004, 232 (3): 823-829.
  • 2Elstrom R, Guan L, Baker G, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood, 2003, 101 (10): 3875-3876.
  • 3Spaepen K, Stroobants S, Dupont P, et al. [(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?. Eur J Nucl Med Mol Imaging, 2003, 30(5): 682-688.
  • 4Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglueose in sareoidosis. J Nuel Med, 1994, 35(10): 1647-1649.
  • 5Tomas MB, Tronco GG, Karayalcin G, et al. FDG uptake in infectious mononucleosis. Clin Positron Imaging, 2000, 3(4): 176.
  • 6Kaste SC, Howard SC, McCarville EB, et al. ^18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's. Pediatr Radiol, 2005, 35(2): 141-154.
  • 7Hong SP, Hahn JS, Lee JD, et al. 18F-fluorodeoxyglucose positron emission tomography in the staging of malignant lymphoma compared with CT and ^67Ga scan. Yonsei Med J, 2003, 44(5): 779-786.
  • 8Israel O, Keidar Z, Bar-Shalom R. Positron emission tomography in the evaluation of lymphoma. Semin Nucl Med, 2004, 34(3): 166-179.
  • 9Kumar R, Maillard I, Schuster SJ, et al. Utility of fluorodeoxyglucose- PET imaging in the management of patients with Hodgkin's and non- Hodgkin's lymphomas. Radiol Clin North Am, 2004, 42(6): 1083-1100.
  • 10Tatsumi M, Cohade C, Nakamoto Y, et al. Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience. Radiology, 2005, 237(3): 1038-1045.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部